 Akira Miyake
Concepts (829)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Individuality | 20 | 2023 | 152 | 3.280 |
Why?
| | Executive Function | 13 | 2019 | 461 | 2.040 |
Why?
| | Memory, Short-Term | 11 | 2021 | 271 | 1.730 |
Why?
| | Cognition | 17 | 2023 | 1266 | 1.440 |
Why?
| | Reading | 8 | 2024 | 136 | 1.410 |
Why?
| | Attention | 15 | 2023 | 457 | 1.400 |
Why?
| | Evoked Potentials | 3 | 2024 | 128 | 1.270 |
Why?
| | Aptitude | 6 | 2017 | 31 | 1.100 |
Why?
| | Self-Control | 3 | 2023 | 55 | 1.020 |
Why?
| | Ego | 3 | 2023 | 10 | 0.850 |
Why?
| | Electroencephalography | 3 | 2024 | 532 | 0.850 |
Why?
| | Memory | 8 | 2016 | 295 | 0.760 |
Why?
| | Comprehension | 3 | 2024 | 180 | 0.710 |
Why?
| | Self Concept | 2 | 2016 | 253 | 0.690 |
Why?
| | Reaction Time | 10 | 2018 | 438 | 0.630 |
Why?
| | Universities | 2 | 2021 | 452 | 0.630 |
Why?
| | Psychomotor Performance | 6 | 2018 | 328 | 0.620 |
Why?
| | Pessimism | 1 | 2019 | 9 | 0.590 |
Why?
| | Internal-External Control | 2 | 2016 | 75 | 0.570 |
Why?
| | Task Performance and Analysis | 3 | 2016 | 198 | 0.560 |
Why?
| | Anxiety | 2 | 2016 | 1109 | 0.550 |
Why?
| | Psycholinguistics | 2 | 2017 | 20 | 0.540 |
Why?
| | Language | 4 | 2024 | 321 | 0.480 |
Why?
| | Mental Recall | 7 | 2008 | 222 | 0.470 |
Why?
| | Students | 3 | 2022 | 663 | 0.460 |
Why?
| | Orientation | 3 | 2002 | 50 | 0.450 |
Why?
| | Epidermal Growth Factor | 5 | 1998 | 171 | 0.450 |
Why?
| | Neuropsychological Tests | 14 | 2017 | 1134 | 0.440 |
Why?
| | Cerebral Cortex | 3 | 2017 | 464 | 0.420 |
Why?
| | Cooperative Behavior | 2 | 2016 | 465 | 0.410 |
Why?
| | Humans | 107 | 2024 | 144759 | 0.400 |
Why?
| | Space Perception | 4 | 2016 | 83 | 0.390 |
Why?
| | Verbal Behavior | 2 | 2004 | 43 | 0.390 |
Why?
| | Interpersonal Relations | 1 | 2016 | 400 | 0.370 |
Why?
| | Learning | 2 | 2022 | 452 | 0.370 |
Why?
| | Female | 76 | 2024 | 78271 | 0.370 |
Why?
| | Racism | 1 | 2015 | 151 | 0.370 |
Why?
| | Cognition Disorders | 4 | 2023 | 538 | 0.360 |
Why?
| | Brain | 5 | 2024 | 2933 | 0.360 |
Why?
| | Ether-A-Go-Go Potassium Channels | 2 | 2009 | 6 | 0.350 |
Why?
| | Young Adult | 17 | 2024 | 14105 | 0.340 |
Why?
| | Physics | 1 | 2010 | 17 | 0.330 |
Why?
| | Cephalosporins | 6 | 1992 | 47 | 0.330 |
Why?
| | Male | 56 | 2024 | 72315 | 0.330 |
Why?
| | Cues | 4 | 2016 | 326 | 0.330 |
Why?
| | Social Values | 1 | 2010 | 40 | 0.320 |
Why?
| | Achievement | 1 | 2010 | 57 | 0.320 |
Why?
| | Frontal Lobe | 3 | 2008 | 160 | 0.300 |
Why?
| | Chromans | 3 | 1994 | 23 | 0.300 |
Why?
| | Verbal Learning | 2 | 2002 | 73 | 0.300 |
Why?
| | Phospholipases A | 3 | 1994 | 98 | 0.290 |
Why?
| | Pattern Recognition, Visual | 3 | 2015 | 105 | 0.290 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2009 | 186 | 0.290 |
Why?
| | Adult | 38 | 2024 | 40449 | 0.280 |
Why?
| | Receptors, Cholecystokinin | 4 | 1997 | 9 | 0.280 |
Why?
| | Heart Defects, Congenital | 4 | 2022 | 914 | 0.270 |
Why?
| | Models, Psychological | 4 | 2016 | 299 | 0.270 |
Why?
| | Adolescent | 28 | 2024 | 22428 | 0.270 |
Why?
| | Problem Solving | 3 | 2008 | 156 | 0.270 |
Why?
| | Goals | 3 | 2015 | 183 | 0.260 |
Why?
| | Potassium Channels | 4 | 2003 | 145 | 0.260 |
Why?
| | Prolactin | 7 | 2000 | 89 | 0.260 |
Why?
| | Transforming Growth Factor alpha | 3 | 1996 | 56 | 0.250 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 3 | 2023 | 428 | 0.250 |
Why?
| | ErbB Receptors | 5 | 1996 | 627 | 0.240 |
Why?
| | Gene-Environment Interaction | 3 | 2017 | 180 | 0.240 |
Why?
| | Pyridazines | 2 | 1997 | 57 | 0.240 |
Why?
| | Thinking | 2 | 2021 | 66 | 0.240 |
Why?
| | Visual Perception | 4 | 2002 | 183 | 0.230 |
Why?
| | Music | 1 | 2006 | 48 | 0.230 |
Why?
| | Decidua | 3 | 1997 | 22 | 0.230 |
Why?
| | Receptors, Serotonin | 4 | 2000 | 35 | 0.230 |
Why?
| | Molecular Sequence Data | 15 | 2008 | 2930 | 0.230 |
Why?
| | Fallopian Tubes | 3 | 1999 | 33 | 0.230 |
Why?
| | Hypoplastic Left Heart Syndrome | 2 | 2018 | 120 | 0.220 |
Why?
| | Receptors, Interleukin | 2 | 1995 | 43 | 0.220 |
Why?
| | Psychological Theory | 2 | 2016 | 93 | 0.220 |
Why?
| | Growth Substances | 4 | 1998 | 140 | 0.220 |
Why?
| | Pituitary Gland | 5 | 1997 | 148 | 0.220 |
Why?
| | Twins, Dizygotic | 4 | 2017 | 109 | 0.210 |
Why?
| | Talc | 1 | 2024 | 9 | 0.210 |
Why?
| | Powders | 1 | 2024 | 44 | 0.210 |
Why?
| | Gene Expression | 7 | 2000 | 1490 | 0.210 |
Why?
| | Semantics | 2 | 2024 | 100 | 0.210 |
Why?
| | Twins, Monozygotic | 4 | 2017 | 134 | 0.210 |
Why?
| | Research Design | 4 | 2021 | 1135 | 0.210 |
Why?
| | Anti-Asthmatic Agents | 2 | 1997 | 251 | 0.200 |
Why?
| | Insecticides | 1 | 2024 | 42 | 0.200 |
Why?
| | RNA, Messenger | 16 | 2000 | 2832 | 0.200 |
Why?
| | Adolescent Development | 2 | 2016 | 72 | 0.200 |
Why?
| | Potassium Channels, Voltage-Gated | 2 | 2002 | 55 | 0.190 |
Why?
| | Phenols | 2 | 1994 | 114 | 0.190 |
Why?
| | Nerve Tissue Proteins | 3 | 2008 | 592 | 0.190 |
Why?
| | Long QT Syndrome | 2 | 2014 | 69 | 0.190 |
Why?
| | Pseudohypoparathyroidism | 1 | 2001 | 3 | 0.180 |
Why?
| | Laryngismus | 1 | 2001 | 10 | 0.180 |
Why?
| | Field Dependence-Independence | 1 | 2001 | 6 | 0.170 |
Why?
| | Blood Alcohol Content | 1 | 2021 | 6 | 0.170 |
Why?
| | Animals | 51 | 2009 | 38058 | 0.170 |
Why?
| | Blotting, Northern | 8 | 1998 | 204 | 0.170 |
Why?
| | Ovarian Neoplasms | 4 | 1999 | 586 | 0.170 |
Why?
| | Japan | 6 | 2024 | 143 | 0.160 |
Why?
| | Reproducibility of Results | 4 | 2016 | 3409 | 0.160 |
Why?
| | Chemotactic Factors | 2 | 1997 | 43 | 0.160 |
Why?
| | Saccades | 2 | 2015 | 45 | 0.160 |
Why?
| | Fibroblast Growth Factors | 2 | 2000 | 188 | 0.160 |
Why?
| | Cell Line | 11 | 2003 | 2882 | 0.160 |
Why?
| | Chemokines, CXC | 2 | 1997 | 68 | 0.160 |
Why?
| | Enzyme Inhibitors | 3 | 2010 | 824 | 0.160 |
Why?
| | Telencephalon | 1 | 1999 | 16 | 0.150 |
Why?
| | 8-Bromo Cyclic Adenosine Monophosphate | 2 | 1996 | 20 | 0.150 |
Why?
| | Amino Acid Sequence | 11 | 2008 | 2155 | 0.150 |
Why?
| | Polymerase Chain Reaction | 8 | 2001 | 1054 | 0.150 |
Why?
| | Interleukin-6 | 4 | 1997 | 780 | 0.150 |
Why?
| | Twins | 4 | 2014 | 156 | 0.140 |
Why?
| | Rats | 19 | 2000 | 5597 | 0.140 |
Why?
| | Surveys and Questionnaires | 5 | 2019 | 6048 | 0.140 |
Why?
| | Scimitar Syndrome | 1 | 2018 | 9 | 0.140 |
Why?
| | Hypothalamus | 2 | 1996 | 153 | 0.140 |
Why?
| | Intercellular Signaling Peptides and Proteins | 2 | 1997 | 381 | 0.140 |
Why?
| | Heterotaxy Syndrome | 1 | 2018 | 14 | 0.140 |
Why?
| | Cardiovascular Surgical Procedures | 1 | 2018 | 30 | 0.140 |
Why?
| | Guidelines as Topic | 1 | 2000 | 267 | 0.130 |
Why?
| | Emotions | 1 | 2023 | 578 | 0.130 |
Why?
| | Mice | 20 | 2009 | 18339 | 0.130 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 4 | 1999 | 168 | 0.130 |
Why?
| | Menstrual Cycle | 2 | 1995 | 140 | 0.130 |
Why?
| | Cystadenocarcinoma | 1 | 1996 | 4 | 0.120 |
Why?
| | CA-125 Antigen | 1 | 1996 | 13 | 0.120 |
Why?
| | Follicle Stimulating Hormone | 8 | 1997 | 249 | 0.120 |
Why?
| | Child Development | 2 | 2012 | 484 | 0.120 |
Why?
| | Tetradecanoylphorbol Acetate | 2 | 1993 | 153 | 0.120 |
Why?
| | Arteriovenous Malformations | 1 | 1996 | 29 | 0.120 |
Why?
| | Estradiol | 4 | 1996 | 533 | 0.120 |
Why?
| | Monosaccharide Transport Proteins | 1 | 1996 | 56 | 0.120 |
Why?
| | Intelligence | 5 | 2011 | 112 | 0.120 |
Why?
| | Calcium | 7 | 2001 | 1183 | 0.120 |
Why?
| | Mice, Inbred ICR | 5 | 1997 | 113 | 0.120 |
Why?
| | Random Allocation | 3 | 2018 | 363 | 0.120 |
Why?
| | Thromboxane-A Synthase | 1 | 1995 | 3 | 0.120 |
Why?
| | Cloning, Molecular | 6 | 2003 | 540 | 0.120 |
Why?
| | Genetic Phenomena | 1 | 2015 | 6 | 0.120 |
Why?
| | Motion Pictures | 1 | 2016 | 21 | 0.120 |
Why?
| | Alcoholic Intoxication | 1 | 2016 | 74 | 0.120 |
Why?
| | Base Sequence | 6 | 2001 | 2190 | 0.120 |
Why?
| | Sample Size | 1 | 2016 | 123 | 0.120 |
Why?
| | Heterocyclic Compounds | 2 | 1992 | 23 | 0.110 |
Why?
| | Association | 1 | 2015 | 12 | 0.110 |
Why?
| | Dangerous Behavior | 1 | 2015 | 17 | 0.110 |
Why?
| | Educational Measurement | 2 | 2010 | 326 | 0.110 |
Why?
| | Genotype | 2 | 2011 | 1833 | 0.110 |
Why?
| | Pregnancy, Animal | 1 | 1994 | 52 | 0.110 |
Why?
| | Arousal | 1 | 2015 | 157 | 0.110 |
Why?
| | 3T3 Cells | 1 | 1994 | 156 | 0.110 |
Why?
| | Dextrocardia | 1 | 2014 | 3 | 0.110 |
Why?
| | Adipose Tissue | 2 | 1997 | 652 | 0.110 |
Why?
| | Phonetics | 2 | 2006 | 40 | 0.110 |
Why?
| | Psychological Tests | 2 | 2008 | 132 | 0.110 |
Why?
| | NAV1.5 Voltage-Gated Sodium Channel | 1 | 2014 | 16 | 0.110 |
Why?
| | Vagina | 1 | 1996 | 201 | 0.110 |
Why?
| | Transplantation, Heterologous | 1 | 1994 | 193 | 0.100 |
Why?
| | Neoplasm Transplantation | 1 | 1994 | 251 | 0.100 |
Why?
| | Genitalia, Female | 1 | 2014 | 42 | 0.100 |
Why?
| | In Vitro Techniques | 4 | 1997 | 1047 | 0.100 |
Why?
| | Alternative Splicing | 2 | 2000 | 247 | 0.100 |
Why?
| | Substance-Related Disorders | 2 | 2017 | 1094 | 0.100 |
Why?
| | Tumor Cells, Cultured | 9 | 2000 | 919 | 0.100 |
Why?
| | Carrageenan | 1 | 1993 | 8 | 0.100 |
Why?
| | Stents | 1 | 2018 | 556 | 0.100 |
Why?
| | Macrophages, Peritoneal | 1 | 1994 | 89 | 0.100 |
Why?
| | Exons | 1 | 1995 | 358 | 0.100 |
Why?
| | Electrocardiography | 2 | 2014 | 662 | 0.100 |
Why?
| | Saliva | 1 | 1995 | 249 | 0.100 |
Why?
| | Recombinant Proteins | 5 | 1999 | 1370 | 0.100 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 2 | 1993 | 338 | 0.100 |
Why?
| | In Situ Hybridization | 6 | 2001 | 319 | 0.100 |
Why?
| | Dinoprostone | 1 | 1994 | 178 | 0.100 |
Why?
| | Ethanol | 1 | 2018 | 627 | 0.100 |
Why?
| | Peptides | 2 | 1996 | 995 | 0.100 |
Why?
| | Pituitary Gland, Anterior | 5 | 1996 | 37 | 0.100 |
Why?
| | Rats, Wistar | 9 | 2000 | 451 | 0.100 |
Why?
| | Wolff-Parkinson-White Syndrome | 1 | 2013 | 19 | 0.100 |
Why?
| | Depression | 2 | 2015 | 1558 | 0.100 |
Why?
| | Data Collection | 1 | 2016 | 633 | 0.100 |
Why?
| | Uterus | 4 | 1999 | 226 | 0.100 |
Why?
| | Phenotype | 5 | 2017 | 3162 | 0.100 |
Why?
| | Dose-Response Relationship, Drug | 8 | 2000 | 2027 | 0.100 |
Why?
| | Adipocytes | 1 | 1994 | 223 | 0.100 |
Why?
| | Motivation | 2 | 2014 | 610 | 0.090 |
Why?
| | Ventricular Fibrillation | 1 | 2013 | 64 | 0.090 |
Why?
| | Sincalide | 4 | 1997 | 5 | 0.090 |
Why?
| | Sequence Homology, Amino Acid | 6 | 2002 | 396 | 0.090 |
Why?
| | Impulsive Behavior | 1 | 2014 | 146 | 0.090 |
Why?
| | Immunohistochemistry | 5 | 1997 | 1716 | 0.090 |
Why?
| | Electrodes, Implanted | 1 | 2013 | 115 | 0.090 |
Why?
| | Tissue Distribution | 5 | 2003 | 327 | 0.090 |
Why?
| | Equol | 1 | 2012 | 5 | 0.090 |
Why?
| | Phytoestrogens | 1 | 2012 | 17 | 0.090 |
Why?
| | Skin Aging | 1 | 2012 | 20 | 0.090 |
Why?
| | Cells, Cultured | 10 | 2001 | 4154 | 0.090 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 1997 | 1217 | 0.090 |
Why?
| | Transfection | 4 | 2003 | 940 | 0.090 |
Why?
| | Magnetic Resonance Imaging | 4 | 2008 | 3863 | 0.090 |
Why?
| | Binding, Competitive | 4 | 2000 | 193 | 0.090 |
Why?
| | DNA, Complementary | 5 | 2001 | 276 | 0.090 |
Why?
| | Biomarkers, Tumor | 2 | 1996 | 1313 | 0.090 |
Why?
| | Hernias, Diaphragmatic, Congenital | 1 | 2014 | 219 | 0.080 |
Why?
| | Alcohol Drinking | 1 | 2018 | 826 | 0.080 |
Why?
| | Factor Analysis, Statistical | 3 | 2011 | 293 | 0.080 |
Why?
| | Glucose | 1 | 1996 | 1047 | 0.080 |
Why?
| | Longitudinal Studies | 6 | 2017 | 2947 | 0.080 |
Why?
| | Hyponatremia | 1 | 2011 | 43 | 0.080 |
Why?
| | Reversal Learning | 1 | 2010 | 10 | 0.080 |
Why?
| | Placenta | 2 | 1997 | 780 | 0.080 |
Why?
| | Structure-Activity Relationship | 5 | 1997 | 570 | 0.080 |
Why?
| | Stereotyping | 1 | 2010 | 47 | 0.080 |
Why?
| | Temperament | 1 | 2010 | 38 | 0.080 |
Why?
| | Pituitary Function Tests | 1 | 1989 | 2 | 0.080 |
Why?
| | Beclin-1 | 1 | 2009 | 11 | 0.080 |
Why?
| | Sodium | 1 | 2011 | 197 | 0.080 |
Why?
| | Autonomic Nervous System | 1 | 2010 | 79 | 0.080 |
Why?
| | Amyloid Precursor Protein Secretases | 1 | 2010 | 77 | 0.080 |
Why?
| | Social Environment | 2 | 2009 | 254 | 0.080 |
Why?
| | Ion Channel Gating | 3 | 2002 | 92 | 0.080 |
Why?
| | Maze Learning | 1 | 2009 | 103 | 0.080 |
Why?
| | Bayes Theorem | 2 | 2022 | 433 | 0.080 |
Why?
| | Postmenopause | 1 | 2012 | 391 | 0.080 |
Why?
| | Microbial Sensitivity Tests | 6 | 1992 | 370 | 0.080 |
Why?
| | Mice, Inbred DBA | 1 | 2009 | 187 | 0.080 |
Why?
| | Pregnancy | 11 | 2022 | 7190 | 0.080 |
Why?
| | Phospholipases A2 | 3 | 1994 | 79 | 0.070 |
Why?
| | Drug Design | 1 | 2010 | 173 | 0.070 |
Why?
| | Patch-Clamp Techniques | 5 | 2003 | 289 | 0.070 |
Why?
| | Defibrillators, Implantable | 1 | 2013 | 382 | 0.070 |
Why?
| | Models, Neurological | 1 | 2011 | 254 | 0.070 |
Why?
| | Gene Expression Regulation | 2 | 1995 | 2608 | 0.070 |
Why?
| | Adipose Tissue, Brown | 2 | 2000 | 59 | 0.070 |
Why?
| | Motor Skills | 1 | 2009 | 104 | 0.070 |
Why?
| | Fontan Procedure | 1 | 2011 | 191 | 0.070 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 1994 | 1455 | 0.070 |
Why?
| | Epilepsy | 1 | 2013 | 376 | 0.070 |
Why?
| | Gonadotropin-Releasing Hormone | 6 | 1997 | 212 | 0.070 |
Why?
| | Heart Failure | 1 | 2022 | 2323 | 0.070 |
Why?
| | Blastocyst | 2 | 2001 | 47 | 0.070 |
Why?
| | Time Factors | 9 | 2011 | 7173 | 0.070 |
Why?
| | Psoriasis | 1 | 2009 | 112 | 0.070 |
Why?
| | Speech Perception | 2 | 2002 | 91 | 0.070 |
Why?
| | Amyloid beta-Peptides | 1 | 2010 | 241 | 0.070 |
Why?
| | Growth Inhibitors | 2 | 1997 | 39 | 0.060 |
Why?
| | Analysis of Variance | 2 | 2004 | 1306 | 0.060 |
Why?
| | Age Factors | 5 | 2016 | 3333 | 0.060 |
Why?
| | Diagnosis, Differential | 4 | 2013 | 1489 | 0.060 |
Why?
| | Conduct Disorder | 1 | 2009 | 160 | 0.060 |
Why?
| | Natriuretic Peptide, Brain | 2 | 2022 | 111 | 0.060 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2009 | 285 | 0.060 |
Why?
| | Trans-Activators | 3 | 2000 | 405 | 0.060 |
Why?
| | Paraventricular Hypothalamic Nucleus | 2 | 1997 | 33 | 0.060 |
Why?
| | RNA, Neoplasm | 2 | 1998 | 86 | 0.060 |
Why?
| | Atrial Fibrillation | 1 | 2013 | 550 | 0.060 |
Why?
| | Infant, Newborn | 4 | 2022 | 6429 | 0.060 |
Why?
| | Kinetics | 7 | 1997 | 1627 | 0.060 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2003 | 983 | 0.060 |
Why?
| | Computer Simulation | 1 | 2011 | 1025 | 0.060 |
Why?
| | Orbital Neoplasms | 1 | 2006 | 27 | 0.060 |
Why?
| | Chromosome Mapping | 2 | 1999 | 510 | 0.060 |
Why?
| | Guinea Pigs | 2 | 1997 | 159 | 0.060 |
Why?
| | Social Behavior | 1 | 2009 | 288 | 0.060 |
Why?
| | Luteinizing Hormone | 6 | 1997 | 190 | 0.060 |
Why?
| | Arachidonic Acid | 3 | 2003 | 101 | 0.060 |
Why?
| | Carcinoma, Transitional Cell | 1 | 2006 | 68 | 0.060 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2008 | 233 | 0.060 |
Why?
| | Endometrial Neoplasms | 2 | 1998 | 208 | 0.060 |
Why?
| | Pituitary Neoplasms | 3 | 2000 | 190 | 0.060 |
Why?
| | Protein-Tyrosine Kinases | 3 | 1997 | 433 | 0.060 |
Why?
| | Epithelium | 3 | 1996 | 314 | 0.060 |
Why?
| | Blotting, Southern | 2 | 1995 | 85 | 0.060 |
Why?
| | Benzodiazepines | 2 | 1997 | 167 | 0.060 |
Why?
| | Proto-Oncogene Proteins | 2 | 2000 | 623 | 0.060 |
Why?
| | Mice, Knockout | 2 | 2009 | 3121 | 0.060 |
Why?
| | Child | 13 | 2019 | 22633 | 0.060 |
Why?
| | Receptors, Interleukin-6 | 2 | 1995 | 47 | 0.060 |
Why?
| | Gram-Negative Bacteria | 4 | 1992 | 81 | 0.050 |
Why?
| | Genes, nef | 1 | 2004 | 1 | 0.050 |
Why?
| | SAIDS Vaccines | 1 | 2004 | 4 | 0.050 |
Why?
| | Genetic Predisposition to Disease | 2 | 2017 | 2363 | 0.050 |
Why?
| | Middle Aged | 13 | 2019 | 35875 | 0.050 |
Why?
| | Sex Factors | 1 | 2010 | 2112 | 0.050 |
Why?
| | Aging | 1 | 1995 | 1966 | 0.050 |
Why?
| | Libraries | 1 | 2024 | 3 | 0.050 |
Why?
| | Books | 1 | 2024 | 2 | 0.050 |
Why?
| | DNA Primers | 2 | 1995 | 512 | 0.050 |
Why?
| | Mice, Transgenic | 1 | 2009 | 2182 | 0.050 |
Why?
| | AIDS Vaccines | 1 | 2004 | 52 | 0.050 |
Why?
| | Hydrocarbons, Chlorinated | 1 | 2024 | 23 | 0.050 |
Why?
| | Severity of Illness Index | 2 | 2009 | 2925 | 0.050 |
Why?
| | Asbestos | 1 | 2024 | 35 | 0.050 |
Why?
| | Norepinephrine | 2 | 2011 | 196 | 0.050 |
Why?
| | Fixation, Ocular | 1 | 2004 | 28 | 0.050 |
Why?
| | Radioimmunoassay | 4 | 1994 | 165 | 0.050 |
Why?
| | Iodine Radioisotopes | 2 | 1994 | 136 | 0.050 |
Why?
| | Glycoproteins | 2 | 1996 | 355 | 0.050 |
Why?
| | Quinidine | 2 | 2003 | 5 | 0.050 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2024 | 131 | 0.050 |
Why?
| | Ion Channels | 2 | 2001 | 129 | 0.050 |
Why?
| | Schizophrenia | 1 | 2008 | 446 | 0.050 |
Why?
| | Muscle Contraction | 3 | 1996 | 429 | 0.050 |
Why?
| | Alzheimer Disease | 1 | 2010 | 621 | 0.050 |
Why?
| | Simian Acquired Immunodeficiency Syndrome | 1 | 2004 | 92 | 0.050 |
Why?
| | Gram-Positive Bacteria | 3 | 1992 | 47 | 0.050 |
Why?
| | Odorants | 1 | 2024 | 116 | 0.050 |
Why?
| | Urinary Bladder Neoplasms | 1 | 2006 | 255 | 0.050 |
Why?
| | Electrophysiology | 5 | 2003 | 218 | 0.050 |
Why?
| | Visual Fields | 2 | 2002 | 115 | 0.050 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 1998 | 905 | 0.050 |
Why?
| | Biguanides | 2 | 2000 | 10 | 0.050 |
Why?
| | Postoperative Complications | 2 | 2018 | 2919 | 0.050 |
Why?
| | Pituitary Hormone-Releasing Hormones | 2 | 1994 | 10 | 0.050 |
Why?
| | Serotonin Receptor Agonists | 2 | 2000 | 27 | 0.050 |
Why?
| | Blotting, Western | 2 | 1995 | 1187 | 0.050 |
Why?
| | Vocabulary | 1 | 2002 | 35 | 0.050 |
Why?
| | Discrimination Learning | 2 | 2008 | 54 | 0.050 |
Why?
| | Concept Formation | 1 | 2002 | 36 | 0.050 |
Why?
| | Anti-Bacterial Agents | 3 | 1992 | 1907 | 0.050 |
Why?
| | Edema | 2 | 1993 | 124 | 0.050 |
Why?
| | Xenopus | 3 | 2001 | 89 | 0.050 |
Why?
| | Rabbits | 3 | 1993 | 648 | 0.050 |
Why?
| | Adolescent Behavior | 1 | 2007 | 501 | 0.050 |
Why?
| | Magnetic Resonance Spectroscopy | 2 | 1997 | 630 | 0.050 |
Why?
| | Dopamine | 2 | 1996 | 283 | 0.050 |
Why?
| | Natriuretic Peptides | 1 | 2022 | 9 | 0.050 |
Why?
| | Mathematics | 1 | 2002 | 100 | 0.040 |
Why?
| | Calcium Compounds | 1 | 2001 | 6 | 0.040 |
Why?
| | Atrial Natriuretic Factor | 1 | 2022 | 57 | 0.040 |
Why?
| | Inflammation | 1 | 1993 | 2878 | 0.040 |
Why?
| | Spatial Behavior | 1 | 2001 | 24 | 0.040 |
Why?
| | Lactates | 1 | 2001 | 83 | 0.040 |
Why?
| | Microsurgery | 1 | 2022 | 72 | 0.040 |
Why?
| | Transcription, Genetic | 4 | 1997 | 1496 | 0.040 |
Why?
| | Hypocalcemia | 1 | 2001 | 38 | 0.040 |
Why?
| | Treatment Outcome | 4 | 2018 | 11679 | 0.040 |
Why?
| | Sequence Alignment | 2 | 1999 | 366 | 0.040 |
Why?
| | Signal Transduction | 5 | 2001 | 5226 | 0.040 |
Why?
| | Interferon-gamma | 1 | 2004 | 784 | 0.040 |
Why?
| | Prevalence | 3 | 2019 | 2834 | 0.040 |
Why?
| | Tritium | 2 | 2000 | 68 | 0.040 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 2 | 1999 | 128 | 0.040 |
Why?
| | Cell Membrane | 2 | 1994 | 706 | 0.040 |
Why?
| | Calcium Channels | 1 | 2001 | 154 | 0.040 |
Why?
| | Neurons | 4 | 1997 | 1640 | 0.040 |
Why?
| | Acute-Phase Proteins | 2 | 1997 | 67 | 0.040 |
Why?
| | Mesoderm | 1 | 2001 | 150 | 0.040 |
Why?
| | Radioligand Assay | 2 | 2000 | 37 | 0.040 |
Why?
| | Membrane Proteins | 3 | 2001 | 1166 | 0.040 |
Why?
| | Predictive Value of Tests | 3 | 2011 | 2115 | 0.040 |
Why?
| | Imagination | 1 | 2000 | 21 | 0.040 |
Why?
| | Hormone Antagonists | 2 | 1997 | 34 | 0.040 |
Why?
| | DNA | 3 | 1995 | 1463 | 0.040 |
Why?
| | Vasodilator Agents | 1 | 2022 | 331 | 0.040 |
Why?
| | Tetraethylammonium | 1 | 1999 | 16 | 0.040 |
Why?
| | Receptors, Eph Family | 1 | 1999 | 6 | 0.040 |
Why?
| | Chromosomes, Human, Pair 12 | 1 | 1999 | 21 | 0.040 |
Why?
| | DNA-Binding Proteins | 2 | 1997 | 1499 | 0.040 |
Why?
| | Evolution, Molecular | 2 | 2008 | 514 | 0.040 |
Why?
| | 3,4-Dihydroxyphenylacetic Acid | 2 | 1996 | 18 | 0.040 |
Why?
| | Immunoblotting | 2 | 1997 | 300 | 0.040 |
Why?
| | Receptor, EphB4 | 1 | 1999 | 33 | 0.040 |
Why?
| | GTP-Binding Proteins | 2 | 1999 | 153 | 0.040 |
Why?
| | Cystadenocarcinoma, Papillary | 1 | 1999 | 4 | 0.040 |
Why?
| | Cytoskeleton | 1 | 2000 | 195 | 0.040 |
Why?
| | Ovariectomy | 2 | 1996 | 162 | 0.040 |
Why?
| | Uterine Contraction | 1 | 1999 | 18 | 0.040 |
Why?
| | Fallopian Tube Neoplasms | 1 | 1999 | 19 | 0.040 |
Why?
| | Phylogeny | 2 | 2003 | 1016 | 0.040 |
Why?
| | Arrhythmias, Cardiac | 1 | 2022 | 361 | 0.040 |
Why?
| | Eosinophils | 1 | 2001 | 316 | 0.040 |
Why?
| | Postpartum Period | 2 | 1999 | 365 | 0.040 |
Why?
| | Enoyl-CoA Hydratase | 1 | 1998 | 12 | 0.040 |
Why?
| | Infant | 5 | 2018 | 10034 | 0.040 |
Why?
| | Monocytes | 1 | 2001 | 538 | 0.040 |
Why?
| | Mice, Inbred C57BL | 1 | 2009 | 5992 | 0.040 |
Why?
| | Glycoprotein Hormones, alpha Subunit | 1 | 1998 | 23 | 0.030 |
Why?
| | Fibroblast Growth Factor 9 | 1 | 1998 | 2 | 0.030 |
Why?
| | Antigens, CD | 1 | 2001 | 555 | 0.030 |
Why?
| | Adenoma | 1 | 2000 | 218 | 0.030 |
Why?
| | Research | 1 | 2001 | 431 | 0.030 |
Why?
| | Muscle, Smooth | 2 | 1996 | 153 | 0.030 |
Why?
| | Spodoptera | 1 | 1998 | 40 | 0.030 |
Why?
| | Binding Sites | 3 | 1999 | 1329 | 0.030 |
Why?
| | Serotonin | 1 | 2000 | 293 | 0.030 |
Why?
| | Actins | 1 | 2000 | 425 | 0.030 |
Why?
| | Baculoviridae | 1 | 1998 | 44 | 0.030 |
Why?
| | Antibody Specificity | 2 | 1997 | 181 | 0.030 |
Why?
| | Progestins | 1 | 1998 | 87 | 0.030 |
Why?
| | Photic Stimulation | 2 | 2018 | 264 | 0.030 |
Why?
| | Carcinoma, Embryonal | 1 | 1997 | 3 | 0.030 |
Why?
| | Species Specificity | 2 | 1996 | 574 | 0.030 |
Why?
| | Retrospective Studies | 4 | 2019 | 17066 | 0.030 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 1999 | 230 | 0.030 |
Why?
| | Peptones | 1 | 1997 | 1 | 0.030 |
Why?
| | Medroxyprogesterone Acetate | 2 | 1998 | 37 | 0.030 |
Why?
| | Gastric Acid | 1 | 1997 | 14 | 0.030 |
Why?
| | Endothelin-1 | 1 | 1999 | 184 | 0.030 |
Why?
| | Placental Lactogen | 1 | 1997 | 17 | 0.030 |
Why?
| | Lymphokines | 1 | 1997 | 130 | 0.030 |
Why?
| | Pulmonary Veins | 1 | 2018 | 105 | 0.030 |
Why?
| | Drainage | 1 | 2018 | 185 | 0.030 |
Why?
| | Leiomyoma | 1 | 1997 | 59 | 0.030 |
Why?
| | Neurosecretory Systems | 1 | 1997 | 31 | 0.030 |
Why?
| | Vaginal Neoplasms | 1 | 1996 | 19 | 0.030 |
Why?
| | Oligopeptides | 2 | 1999 | 269 | 0.030 |
Why?
| | Arcuate Nucleus of Hypothalamus | 1 | 1996 | 12 | 0.030 |
Why?
| | Tissue Polypeptide Antigen | 1 | 1996 | 2 | 0.030 |
Why?
| | Culture Media, Conditioned | 1 | 1997 | 111 | 0.030 |
Why?
| | Depression, Chemical | 1 | 1996 | 16 | 0.030 |
Why?
| | Cell Division | 2 | 2000 | 766 | 0.030 |
Why?
| | Receptors, Transforming Growth Factor beta | 1 | 1996 | 57 | 0.030 |
Why?
| | Uterine Neoplasms | 1 | 1997 | 96 | 0.030 |
Why?
| | Oxytocin | 1 | 1996 | 51 | 0.030 |
Why?
| | Phenylurea Compounds | 1 | 1997 | 112 | 0.030 |
Why?
| | Glucose Transporter Type 1 | 1 | 1996 | 48 | 0.030 |
Why?
| | Deoxyglucose | 1 | 1996 | 51 | 0.030 |
Why?
| | Cytoplasm | 1 | 1997 | 269 | 0.030 |
Why?
| | Molecular Structure | 1 | 1997 | 499 | 0.030 |
Why?
| | Carcinoma | 1 | 1998 | 228 | 0.030 |
Why?
| | Membrane Potentials | 4 | 2001 | 280 | 0.030 |
Why?
| | Transcriptional Activation | 1 | 1998 | 383 | 0.030 |
Why?
| | Neoplasm Staging | 2 | 1998 | 1462 | 0.030 |
Why?
| | Potassium Channels, Inwardly Rectifying | 1 | 1996 | 44 | 0.030 |
Why?
| | Immune Sera | 1 | 1995 | 77 | 0.030 |
Why?
| | Coenzyme A Ligases | 1 | 1995 | 15 | 0.030 |
Why?
| | Platelet Activating Factor | 1 | 1995 | 49 | 0.030 |
Why?
| | Theophylline | 1 | 1995 | 41 | 0.030 |
Why?
| | Trophoblasts | 1 | 1998 | 216 | 0.030 |
Why?
| | Submandibular Gland | 1 | 1995 | 20 | 0.030 |
Why?
| | Recurrence | 1 | 2019 | 1135 | 0.030 |
Why?
| | Meta-Analysis as Topic | 1 | 2016 | 174 | 0.030 |
Why?
| | Receptors, Serotonin, 5-HT3 | 3 | 2000 | 16 | 0.030 |
Why?
| | Neoplasm Proteins | 1 | 1998 | 442 | 0.030 |
Why?
| | Lipoprotein Lipase | 1 | 1995 | 56 | 0.030 |
Why?
| | Restriction Mapping | 1 | 1995 | 80 | 0.030 |
Why?
| | Piperazines | 2 | 2000 | 381 | 0.030 |
Why?
| | Mice, Inbred C3H | 1 | 1995 | 251 | 0.030 |
Why?
| | Genetic Heterogeneity | 1 | 1995 | 62 | 0.030 |
Why?
| | Brain Chemistry | 1 | 1995 | 116 | 0.030 |
Why?
| | Biological Transport | 1 | 1996 | 417 | 0.030 |
Why?
| | Azepines | 2 | 2010 | 107 | 0.030 |
Why?
| | Gastric Mucosa | 1 | 1995 | 52 | 0.030 |
Why?
| | Thyrotropin-Releasing Hormone | 3 | 1997 | 11 | 0.030 |
Why?
| | Statistics as Topic | 1 | 2016 | 284 | 0.030 |
Why?
| | Cystadenocarcinoma, Mucinous | 1 | 1994 | 12 | 0.030 |
Why?
| | Molecular Chaperones | 1 | 1996 | 200 | 0.030 |
Why?
| | Salivary Glands | 1 | 1994 | 36 | 0.030 |
Why?
| | Infertility, Male | 2 | 1985 | 73 | 0.030 |
Why?
| | Inhibins | 1 | 1994 | 41 | 0.030 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 1997 | 851 | 0.030 |
Why?
| | Protein Biosynthesis | 1 | 1997 | 458 | 0.030 |
Why?
| | Vibration | 2 | 1988 | 71 | 0.030 |
Why?
| | Receptor, Cholecystokinin B | 1 | 1994 | 1 | 0.030 |
Why?
| | Gastrins | 1 | 1994 | 8 | 0.030 |
Why?
| | Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 1994 | 15 | 0.030 |
Why?
| | Bronchodilator Agents | 1 | 1995 | 182 | 0.030 |
Why?
| | Haplorhini | 1 | 1994 | 52 | 0.030 |
Why?
| | Embolization, Therapeutic | 1 | 1996 | 242 | 0.030 |
Why?
| | RNA-Directed DNA Polymerase | 1 | 1994 | 35 | 0.030 |
Why?
| | HTLV-I Infections | 1 | 1994 | 28 | 0.030 |
Why?
| | Gestational Age | 1 | 1997 | 975 | 0.030 |
Why?
| | Transforming Growth Factor beta | 1 | 1996 | 479 | 0.030 |
Why?
| | Eye Infections, Viral | 1 | 1994 | 12 | 0.030 |
Why?
| | Receptors, Fibroblast Growth Factor | 1 | 1994 | 69 | 0.030 |
Why?
| | Pleurisy | 1 | 1993 | 6 | 0.030 |
Why?
| | Cystadenocarcinoma, Serous | 1 | 1994 | 84 | 0.030 |
Why?
| | Vestibular Nuclei | 1 | 1973 | 7 | 0.030 |
Why?
| | Ear, External | 1 | 1993 | 21 | 0.030 |
Why?
| | Lipoxygenase Inhibitors | 1 | 1993 | 34 | 0.020 |
Why?
| | Hydrolysis | 1 | 1994 | 199 | 0.020 |
Why?
| | Posture | 2 | 1988 | 196 | 0.020 |
Why?
| | Receptors, Estrogen | 1 | 1996 | 457 | 0.020 |
Why?
| | Trachea | 1 | 1995 | 261 | 0.020 |
Why?
| | Cyclooxygenase Inhibitors | 1 | 1993 | 81 | 0.020 |
Why?
| | Neuropeptides | 1 | 1993 | 77 | 0.020 |
Why?
| | Cardiac Conduction System Disease | 1 | 2013 | 3 | 0.020 |
Why?
| | Neurotransmitter Uptake Inhibitors | 1 | 1993 | 3 | 0.020 |
Why?
| | Reference Values | 2 | 1997 | 797 | 0.020 |
Why?
| | Lipopolysaccharides | 1 | 1997 | 863 | 0.020 |
Why?
| | Survival Rate | 1 | 2018 | 2089 | 0.020 |
Why?
| | Gestrinone | 1 | 1992 | 1 | 0.020 |
Why?
| | Heart Ventricles | 1 | 2018 | 760 | 0.020 |
Why?
| | Down-Regulation | 1 | 1995 | 627 | 0.020 |
Why?
| | Extracellular Space | 1 | 1993 | 120 | 0.020 |
Why?
| | Embryo, Mammalian | 1 | 1994 | 232 | 0.020 |
Why?
| | T-Lymphocytes | 1 | 2001 | 1982 | 0.020 |
Why?
| | Mice, Nude | 1 | 1994 | 682 | 0.020 |
Why?
| | Cyclic AMP | 1 | 1993 | 209 | 0.020 |
Why?
| | Cerebral Ventricles | 1 | 1993 | 54 | 0.020 |
Why?
| | Receptors, Cell Surface | 2 | 1985 | 377 | 0.020 |
Why?
| | Myocardium | 1 | 1998 | 939 | 0.020 |
Why?
| | Therapy, Computer-Assisted | 1 | 2013 | 64 | 0.020 |
Why?
| | Androgen-Insensitivity Syndrome | 2 | 1985 | 3 | 0.020 |
Why?
| | Mothers | 1 | 2019 | 775 | 0.020 |
Why?
| | Child, Preschool | 6 | 2011 | 11787 | 0.020 |
Why?
| | Cefmenoxime | 1 | 1992 | 1 | 0.020 |
Why?
| | Energy Intake | 1 | 1995 | 499 | 0.020 |
Why?
| | Uveitis | 1 | 1994 | 148 | 0.020 |
Why?
| | Phospholipids | 1 | 1994 | 213 | 0.020 |
Why?
| | Apoptosis | 2 | 2001 | 2430 | 0.020 |
Why?
| | Triglycerides | 1 | 1994 | 520 | 0.020 |
Why?
| | Mutation, Missense | 1 | 2014 | 340 | 0.020 |
Why?
| | Isoflavones | 1 | 2012 | 26 | 0.020 |
Why?
| | Dihydrotestosterone | 2 | 1996 | 42 | 0.020 |
Why?
| | Genetics, Behavioral | 1 | 2011 | 17 | 0.020 |
Why?
| | Social Control, Informal | 1 | 2011 | 21 | 0.020 |
Why?
| | Placebos | 1 | 2012 | 192 | 0.020 |
Why?
| | Weight Gain | 1 | 1995 | 556 | 0.020 |
Why?
| | Proteins | 1 | 1997 | 1021 | 0.020 |
Why?
| | Models, Genetic | 1 | 2014 | 536 | 0.020 |
Why?
| | Central Venous Pressure | 1 | 2011 | 16 | 0.020 |
Why?
| | Pain | 1 | 1997 | 779 | 0.020 |
Why?
| | Renin | 1 | 2011 | 34 | 0.020 |
Why?
| | Equipment Design | 1 | 2013 | 530 | 0.020 |
Why?
| | Peptides, Cyclic | 1 | 1993 | 275 | 0.020 |
Why?
| | Arginine Vasopressin | 1 | 2011 | 44 | 0.020 |
Why?
| | Death, Sudden, Cardiac | 1 | 2013 | 230 | 0.020 |
Why?
| | Lipid Metabolism | 1 | 1994 | 527 | 0.020 |
Why?
| | Ovary | 1 | 1992 | 228 | 0.020 |
Why?
| | Stroop Test | 1 | 2010 | 24 | 0.020 |
Why?
| | Flurbiprofen | 1 | 2010 | 3 | 0.020 |
Why?
| | Sheep | 1 | 1993 | 880 | 0.020 |
Why?
| | Testis | 3 | 1985 | 163 | 0.020 |
Why?
| | Aspartic Acid Endopeptidases | 1 | 2010 | 32 | 0.020 |
Why?
| | Hyperprolactinemia | 1 | 1990 | 6 | 0.020 |
Why?
| | Prolactinoma | 1 | 1990 | 13 | 0.020 |
Why?
| | Cell Differentiation | 2 | 1997 | 2050 | 0.020 |
Why?
| | Chi-Square Distribution | 1 | 2011 | 529 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2014 | 1539 | 0.020 |
Why?
| | Amyloid beta-Protein Precursor | 1 | 2010 | 64 | 0.020 |
Why?
| | Dermatologic Agents | 2 | 2009 | 68 | 0.020 |
Why?
| | Taurine | 1 | 2010 | 41 | 0.020 |
Why?
| | Gene Deletion | 2 | 2004 | 389 | 0.020 |
Why?
| | Ovarian Diseases | 1 | 1989 | 13 | 0.020 |
Why?
| | Pituitary Diseases | 1 | 1989 | 20 | 0.020 |
Why?
| | Hypothalamic Diseases | 1 | 1989 | 17 | 0.020 |
Why?
| | Environment | 1 | 2011 | 305 | 0.020 |
Why?
| | Risk Factors | 2 | 2017 | 10779 | 0.020 |
Why?
| | Sensitivity and Specificity | 2 | 2009 | 1985 | 0.020 |
Why?
| | Electric Conductivity | 2 | 2002 | 84 | 0.020 |
Why?
| | Alanine | 1 | 2010 | 171 | 0.020 |
Why?
| | Adenocarcinoma | 1 | 1996 | 928 | 0.020 |
Why?
| | Neural Pathways | 1 | 2011 | 311 | 0.020 |
Why?
| | Infertility, Female | 1 | 1990 | 112 | 0.020 |
Why?
| | Color | 1 | 2009 | 81 | 0.020 |
Why?
| | HIV Infections | 1 | 2004 | 3154 | 0.020 |
Why?
| | Follow-Up Studies | 2 | 2010 | 5408 | 0.020 |
Why?
| | Calibration | 1 | 2009 | 151 | 0.020 |
Why?
| | Attention Deficit and Disruptive Behavior Disorders | 1 | 2009 | 56 | 0.020 |
Why?
| | Photography | 1 | 2009 | 115 | 0.020 |
Why?
| | Regression Analysis | 1 | 2011 | 1003 | 0.020 |
Why?
| | Kaplan-Meier Estimate | 1 | 2011 | 965 | 0.020 |
Why?
| | Protein Binding | 1 | 1994 | 2273 | 0.020 |
Why?
| | Cyclosporine | 1 | 2009 | 265 | 0.020 |
Why?
| | Oxygen Consumption | 1 | 2011 | 724 | 0.020 |
Why?
| | Intelligence Tests | 1 | 2007 | 56 | 0.020 |
Why?
| | Schizophrenic Psychology | 1 | 2008 | 97 | 0.020 |
Why?
| | Antigens, Neoplasm | 1 | 1989 | 271 | 0.020 |
Why?
| | Dietary Supplements | 1 | 2012 | 576 | 0.020 |
Why?
| | Estrogens, Conjugated (USP) | 2 | 1978 | 52 | 0.020 |
Why?
| | Kidney | 1 | 1995 | 1495 | 0.020 |
Why?
| | Proportional Hazards Models | 1 | 2011 | 1325 | 0.020 |
Why?
| | Janus Kinase 1 | 2 | 1997 | 26 | 0.020 |
Why?
| | Neurons, Afferent | 1 | 1988 | 102 | 0.020 |
Why?
| | Injections, Intravenous | 2 | 2004 | 200 | 0.020 |
Why?
| | Organ Size | 1 | 2008 | 463 | 0.020 |
Why?
| | Protein Kinase C | 2 | 1999 | 252 | 0.020 |
Why?
| | Double-Blind Method | 1 | 2012 | 2029 | 0.020 |
Why?
| | Foot | 1 | 1988 | 100 | 0.020 |
Why?
| | Bromocriptine | 2 | 1990 | 31 | 0.020 |
Why?
| | Enzyme Activation | 2 | 1999 | 766 | 0.020 |
Why?
| | Faculty | 1 | 2007 | 149 | 0.020 |
Why?
| | Cystectomy | 1 | 2006 | 41 | 0.020 |
Why?
| | Menotropins | 1 | 1985 | 2 | 0.010 |
Why?
| | Pilot Projects | 1 | 2012 | 1886 | 0.010 |
Why?
| | Thalamic Nuclei | 2 | 1984 | 9 | 0.010 |
Why?
| | Fatal Outcome | 1 | 2006 | 307 | 0.010 |
Why?
| | Progesterone | 3 | 1996 | 255 | 0.010 |
Why?
| | Preoperative Care | 2 | 1999 | 379 | 0.010 |
Why?
| | Ophthalmologic Surgical Procedures | 1 | 2006 | 90 | 0.010 |
Why?
| | Molecular Weight | 2 | 1996 | 327 | 0.010 |
Why?
| | Alleles | 1 | 2008 | 879 | 0.010 |
Why?
| | Aged | 5 | 2006 | 25913 | 0.010 |
Why?
| | Behavior, Animal | 1 | 2008 | 519 | 0.010 |
Why?
| | Neutralization Tests | 1 | 2004 | 76 | 0.010 |
Why?
| | Models, Biological | 2 | 2003 | 1821 | 0.010 |
Why?
| | HIV Antibodies | 1 | 2004 | 60 | 0.010 |
Why?
| | Cats | 4 | 1984 | 228 | 0.010 |
Why?
| | Vaccines, Synthetic | 1 | 2004 | 138 | 0.010 |
Why?
| | Simian Immunodeficiency Virus | 1 | 2004 | 92 | 0.010 |
Why?
| | CD4 Lymphocyte Count | 1 | 2004 | 277 | 0.010 |
Why?
| | Vaccines, Attenuated | 1 | 2004 | 129 | 0.010 |
Why?
| | Macaca mulatta | 1 | 2004 | 191 | 0.010 |
Why?
| | Phosphorylation | 2 | 1999 | 1732 | 0.010 |
Why?
| | Comorbidity | 1 | 2009 | 1658 | 0.010 |
Why?
| | Propafenone | 1 | 2003 | 2 | 0.010 |
Why?
| | Barium | 1 | 2003 | 27 | 0.010 |
Why?
| | Ethanolamines | 1 | 2003 | 14 | 0.010 |
Why?
| | Quinine | 1 | 2003 | 21 | 0.010 |
Why?
| | Recombination, Genetic | 1 | 2004 | 205 | 0.010 |
Why?
| | Glyburide | 1 | 2003 | 31 | 0.010 |
Why?
| | HIV | 1 | 2004 | 250 | 0.010 |
Why?
| | Lidocaine | 1 | 2003 | 54 | 0.010 |
Why?
| | Biopsy | 1 | 2006 | 1075 | 0.010 |
Why?
| | Docosahexaenoic Acids | 1 | 2003 | 83 | 0.010 |
Why?
| | Fatty Acids, Nonesterified | 1 | 2003 | 158 | 0.010 |
Why?
| | Lymphocytes | 1 | 2004 | 382 | 0.010 |
Why?
| | Delayed Rectifier Potassium Channels | 1 | 2002 | 9 | 0.010 |
Why?
| | Anti-Arrhythmia Agents | 1 | 2003 | 142 | 0.010 |
Why?
| | Shab Potassium Channels | 1 | 2002 | 20 | 0.010 |
Why?
| | Viral Load | 1 | 2004 | 526 | 0.010 |
Why?
| | Protein Kinase Inhibitors | 2 | 1999 | 969 | 0.010 |
Why?
| | NAD+ Nucleosidase | 1 | 2001 | 3 | 0.010 |
Why?
| | ADP-ribosyl Cyclase | 1 | 2001 | 6 | 0.010 |
Why?
| | Adenosine Diphosphate Ribose | 1 | 2001 | 5 | 0.010 |
Why?
| | Analgesics, Non-Narcotic | 1 | 2003 | 123 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2003 | 561 | 0.010 |
Why?
| | ADP-ribosyl Cyclase 1 | 1 | 2001 | 43 | 0.010 |
Why?
| | Fetal Proteins | 1 | 2001 | 15 | 0.010 |
Why?
| | Antigens, Differentiation | 1 | 2001 | 77 | 0.010 |
Why?
| | Jurkat Cells | 1 | 2001 | 114 | 0.010 |
Why?
| | Prognosis | 1 | 2010 | 4282 | 0.010 |
Why?
| | Aptitude Tests | 1 | 2001 | 4 | 0.010 |
Why?
| | Risk Assessment | 1 | 2011 | 3671 | 0.010 |
Why?
| | Perciformes | 1 | 2001 | 19 | 0.010 |
Why?
| | Clomiphene | 1 | 1981 | 15 | 0.010 |
Why?
| | Muscle Spindles | 1 | 1981 | 6 | 0.010 |
Why?
| | Twin Studies as Topic | 1 | 2001 | 14 | 0.010 |
Why?
| | Protein Subunits | 1 | 2002 | 226 | 0.010 |
Why?
| | NAD | 1 | 2001 | 81 | 0.010 |
Why?
| | Amenorrhea | 1 | 1981 | 31 | 0.010 |
Why?
| | Phalloidine | 1 | 2000 | 3 | 0.010 |
Why?
| | Cytochalasin B | 1 | 2000 | 8 | 0.010 |
Why?
| | Ovulation Induction | 1 | 1981 | 56 | 0.010 |
Why?
| | TRPM Cation Channels | 1 | 2001 | 75 | 0.010 |
Why?
| | Lung | 1 | 2014 | 4109 | 0.010 |
Why?
| | Protein Structure, Tertiary | 1 | 2003 | 862 | 0.010 |
Why?
| | Stimulation, Chemical | 1 | 2000 | 53 | 0.010 |
Why?
| | Kruppel-Like Factor 6 | 1 | 2000 | 1 | 0.010 |
Why?
| | Tubocurarine | 1 | 2000 | 6 | 0.010 |
Why?
| | Ondansetron | 1 | 2000 | 19 | 0.010 |
Why?
| | T-Box Domain Proteins | 1 | 2001 | 106 | 0.010 |
Why?
| | Serotonin Antagonists | 1 | 2000 | 30 | 0.010 |
Why?
| | Uncoupling Agents | 1 | 2000 | 4 | 0.010 |
Why?
| | Uncoupling Protein 1 | 1 | 2000 | 17 | 0.010 |
Why?
| | RNA, Viral | 1 | 2004 | 688 | 0.010 |
Why?
| | Skin | 1 | 1985 | 755 | 0.010 |
Why?
| | Spinal Cord | 1 | 2003 | 380 | 0.010 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2008 | 2145 | 0.010 |
Why?
| | Ferrets | 1 | 2000 | 31 | 0.010 |
Why?
| | Antibodies, Viral | 1 | 2004 | 672 | 0.010 |
Why?
| | Exocytosis | 1 | 2000 | 84 | 0.010 |
Why?
| | Fatty Acids | 1 | 2003 | 450 | 0.010 |
Why?
| | Cerebellar Nuclei | 1 | 1980 | 9 | 0.010 |
Why?
| | Kruppel-Like Transcription Factors | 1 | 2000 | 78 | 0.010 |
Why?
| | Actin Cytoskeleton | 1 | 2000 | 103 | 0.010 |
Why?
| | Fibroblasts | 1 | 1985 | 1034 | 0.010 |
Why?
| | Biomarkers | 1 | 2011 | 4271 | 0.010 |
Why?
| | Microscopy, Confocal | 1 | 2000 | 321 | 0.010 |
Why?
| | Ritodrine | 1 | 1999 | 1 | 0.010 |
Why?
| | Son of Sevenless Proteins | 1 | 1999 | 4 | 0.010 |
Why?
| | Virulence Factors, Bordetella | 1 | 1999 | 15 | 0.010 |
Why?
| | Clinical Protocols | 1 | 2001 | 282 | 0.010 |
Why?
| | Pertussis Toxin | 1 | 1999 | 24 | 0.010 |
Why?
| | Imidazoles | 1 | 2000 | 254 | 0.010 |
Why?
| | Endothelin Receptor Antagonists | 1 | 1999 | 62 | 0.010 |
Why?
| | Receptor, Endothelin A | 1 | 1999 | 63 | 0.010 |
Why?
| | Ion Transport | 1 | 1999 | 63 | 0.010 |
Why?
| | Adenosine Triphosphate | 1 | 2001 | 498 | 0.010 |
Why?
| | Membrane Glycoproteins | 1 | 2001 | 496 | 0.010 |
Why?
| | Cations | 1 | 1999 | 82 | 0.010 |
Why?
| | Cold Temperature | 1 | 2000 | 209 | 0.010 |
Why?
| | Permeability | 1 | 1999 | 168 | 0.010 |
Why?
| | Hemolytic Plaque Technique | 1 | 1997 | 28 | 0.010 |
Why?
| | Secretory Rate | 1 | 1997 | 12 | 0.010 |
Why?
| | Oocytes | 1 | 1999 | 178 | 0.010 |
Why?
| | Proto-Oncogene Proteins c-raf | 1 | 1997 | 45 | 0.010 |
Why?
| | Zebrafish Proteins | 1 | 2001 | 311 | 0.010 |
Why?
| | MAP Kinase Kinase 2 | 1 | 1997 | 29 | 0.010 |
Why?
| | Mitochondrial Proteins | 1 | 2000 | 262 | 0.010 |
Why?
| | Cervix Uteri | 1 | 1998 | 50 | 0.010 |
Why?
| | Endometrium | 1 | 1998 | 61 | 0.010 |
Why?
| | Gadolinium DTPA | 1 | 1998 | 68 | 0.010 |
Why?
| | Leukemia Inhibitory Factor | 1 | 1997 | 6 | 0.010 |
Why?
| | Prospective Studies | 1 | 2010 | 7990 | 0.010 |
Why?
| | Postural Balance | 1 | 1981 | 240 | 0.010 |
Why?
| | MAP Kinase Kinase 1 | 1 | 1997 | 71 | 0.010 |
Why?
| | Myometrium | 1 | 1998 | 38 | 0.010 |
Why?
| | Famotidine | 1 | 1997 | 1 | 0.010 |
Why?
| | Pentagastrin | 1 | 1997 | 3 | 0.010 |
Why?
| | Devazepide | 1 | 1997 | 4 | 0.010 |
Why?
| | Benzodiazepinones | 1 | 1997 | 18 | 0.010 |
Why?
| | Pituitary Gland, Posterior | 1 | 1997 | 3 | 0.010 |
Why?
| | Atropine | 1 | 1997 | 37 | 0.010 |
Why?
| | Genes, ras | 1 | 1997 | 96 | 0.010 |
Why?
| | Methacholine Chloride | 1 | 1997 | 50 | 0.010 |
Why?
| | Janus Kinase 2 | 1 | 1997 | 29 | 0.010 |
Why?
| | Colorado | 1 | 2007 | 4564 | 0.010 |
Why?
| | Colchicine | 1 | 1997 | 21 | 0.010 |
Why?
| | STAT1 Transcription Factor | 1 | 1997 | 68 | 0.010 |
Why?
| | Injections, Intraventricular | 1 | 1997 | 56 | 0.010 |
Why?
| | Muscarinic Antagonists | 1 | 1997 | 30 | 0.010 |
Why?
| | Sequence Analysis, DNA | 1 | 2000 | 824 | 0.010 |
Why?
| | Luciferases | 1 | 1997 | 152 | 0.010 |
Why?
| | Histamine | 1 | 1997 | 53 | 0.010 |
Why?
| | Antineoplastic Agents, Hormonal | 1 | 1998 | 194 | 0.010 |
Why?
| | Histamine H2 Antagonists | 1 | 1997 | 23 | 0.010 |
Why?
| | Tyrosine | 1 | 1997 | 222 | 0.010 |
Why?
| | Clusterin | 1 | 1996 | 11 | 0.010 |
Why?
| | Chemokine CXCL1 | 1 | 1997 | 76 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2004 | 2496 | 0.010 |
Why?
| | Stomach | 1 | 1997 | 109 | 0.010 |
Why?
| | Formaldehyde | 1 | 1997 | 66 | 0.010 |
Why?
| | Psychometrics | 1 | 2001 | 734 | 0.010 |
Why?
| | Gene Transfer Techniques | 1 | 1998 | 185 | 0.010 |
Why?
| | Stereoisomerism | 1 | 1996 | 104 | 0.010 |
Why?
| | G Protein-Coupled Inwardly-Rectifying Potassium Channels | 1 | 1996 | 10 | 0.010 |
Why?
| | Indoles | 1 | 2000 | 501 | 0.010 |
Why?
| | Neoplasm Invasiveness | 1 | 1998 | 508 | 0.010 |
Why?
| | Recombinant Fusion Proteins | 1 | 1999 | 675 | 0.010 |
Why?
| | Leptin | 1 | 1997 | 245 | 0.010 |
Why?
| | Carrier Proteins | 1 | 2000 | 737 | 0.010 |
Why?
| | Tomography, X-Ray Computed | 1 | 2006 | 2730 | 0.010 |
Why?
| | Seizures | 1 | 1980 | 460 | 0.010 |
Why?
| | ROC Curve | 1 | 1998 | 614 | 0.010 |
Why?
| | Vaccination | 1 | 2004 | 1423 | 0.010 |
Why?
| | Dogs | 1 | 1997 | 437 | 0.010 |
Why?
| | Chorionic Gonadotropin | 1 | 1976 | 77 | 0.010 |
Why?
| | Conjugation, Genetic | 1 | 1975 | 5 | 0.010 |
Why?
| | Microscopy, Electron | 1 | 1996 | 415 | 0.010 |
Why?
| | Mannose | 1 | 1975 | 23 | 0.010 |
Why?
| | Glucosamine | 1 | 1975 | 14 | 0.010 |
Why?
| | Receptors, FSH | 2 | 1985 | 9 | 0.010 |
Why?
| | STAT3 Transcription Factor | 1 | 1997 | 207 | 0.010 |
Why?
| | Ciliophora | 1 | 1975 | 15 | 0.010 |
Why?
| | Electric Stimulation | 2 | 1973 | 276 | 0.010 |
Why?
| | Chlorides | 1 | 1996 | 142 | 0.010 |
Why?
| | Dendrites | 1 | 1996 | 106 | 0.010 |
Why?
| | Activins | 1 | 1994 | 29 | 0.010 |
Why?
| | Growth Hormone-Releasing Hormone | 1 | 1994 | 19 | 0.010 |
Why?
| | Contrast Media | 1 | 1998 | 488 | 0.010 |
Why?
| | Polycystic Ovary Syndrome | 1 | 1977 | 180 | 0.010 |
Why?
| | Cross-Cultural Comparison | 1 | 1995 | 84 | 0.010 |
Why?
| | gamma-Aminobutyric Acid | 1 | 1996 | 192 | 0.010 |
Why?
| | Dexamethasone | 1 | 1996 | 372 | 0.010 |
Why?
| | Axons | 1 | 1996 | 201 | 0.010 |
Why?
| | Eating | 1 | 1997 | 389 | 0.010 |
Why?
| | Adenosine | 1 | 1996 | 255 | 0.010 |
Why?
| | Corticotropin-Releasing Hormone | 1 | 1994 | 72 | 0.010 |
Why?
| | HTLV-I Antibodies | 1 | 1994 | 6 | 0.010 |
Why?
| | Pituitary Adenylate Cyclase-Activating Polypeptide | 1 | 1993 | 3 | 0.010 |
Why?
| | Vasoactive Intestinal Peptide | 1 | 1993 | 20 | 0.010 |
Why?
| | Human T-lymphotropic virus 1 | 1 | 1994 | 32 | 0.010 |
Why?
| | Mice, Inbred BALB C | 1 | 1996 | 1253 | 0.010 |
Why?
| | Cytosol | 1 | 1994 | 227 | 0.010 |
Why?
| | Muscles | 2 | 1988 | 333 | 0.010 |
Why?
| | Estrogens | 1 | 1996 | 380 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2004 | 4557 | 0.010 |
Why?
| | Natural Language Processing | 1 | 1995 | 103 | 0.010 |
Why?
| | Seroepidemiologic Studies | 1 | 1994 | 172 | 0.010 |
Why?
| | Benztropine | 1 | 1993 | 1 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 1998 | 1257 | 0.010 |
Why?
| | Organ Specificity | 1 | 1994 | 312 | 0.010 |
Why?
| | Infusions, Parenteral | 1 | 1993 | 41 | 0.010 |
Why?
| | Dopamine Antagonists | 1 | 1993 | 25 | 0.010 |
Why?
| | Gonadotropins, Equine | 1 | 1992 | 2 | 0.010 |
Why?
| | Hypophysectomy | 1 | 1992 | 15 | 0.010 |
Why?
| | Aldehyde-Lyases | 1 | 1992 | 3 | 0.010 |
Why?
| | 3-Hydroxysteroid Dehydrogenases | 1 | 1992 | 9 | 0.010 |
Why?
| | Steroid 17-alpha-Hydroxylase | 1 | 1992 | 5 | 0.010 |
Why?
| | 17-Hydroxysteroid Dehydrogenases | 1 | 1992 | 4 | 0.010 |
Why?
| | Aromatase | 1 | 1992 | 32 | 0.010 |
Why?
| | Visual Cortex | 1 | 1973 | 84 | 0.010 |
Why?
| | Electromyography | 2 | 1988 | 415 | 0.010 |
Why?
| | beta-Lactamases | 1 | 1992 | 51 | 0.010 |
Why?
| | Synapses | 1 | 1996 | 439 | 0.010 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 1992 | 162 | 0.010 |
Why?
| | Cortical Spreading Depression | 1 | 1971 | 9 | 0.010 |
Why?
| | Oligodendroglia | 1 | 1994 | 187 | 0.010 |
Why?
| | Androgens | 1 | 1992 | 186 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 1997 | 2527 | 0.010 |
Why?
| | Amino Acids | 1 | 1975 | 521 | 0.010 |
Why?
| | Neuroglia | 1 | 1971 | 172 | 0.000 |
Why?
| | Epithelial Cells | 1 | 1996 | 1125 | 0.000 |
Why?
| | Bacterial Infections | 1 | 1992 | 246 | 0.000 |
Why?
| | Monitoring, Immunologic | 1 | 1989 | 23 | 0.000 |
Why?
| | Carcinoembryonic Antigen | 1 | 1989 | 38 | 0.000 |
Why?
| | Dermoid Cyst | 1 | 1989 | 14 | 0.000 |
Why?
| | Visual Pathways | 2 | 1984 | 61 | 0.000 |
Why?
| | Mutation | 1 | 1999 | 4089 | 0.000 |
Why?
| | Testosterone | 2 | 1984 | 419 | 0.000 |
Why?
| | Incidence | 1 | 1994 | 2879 | 0.000 |
Why?
| | Methoxyflurane | 1 | 1966 | 2 | 0.000 |
Why?
| | RNA | 1 | 1993 | 940 | 0.000 |
Why?
| | Acid-Base Equilibrium | 1 | 1966 | 24 | 0.000 |
Why?
| | Gonadal Dysgenesis | 1 | 1985 | 7 | 0.000 |
Why?
| | Turner Syndrome | 1 | 1985 | 64 | 0.000 |
Why?
| | Hypothermia, Induced | 1 | 1966 | 96 | 0.000 |
Why?
| | Ischemia | 1 | 1988 | 421 | 0.000 |
Why?
| | Spermatogenesis | 1 | 1984 | 91 | 0.000 |
Why?
| | Obesity | 1 | 1997 | 3077 | 0.000 |
Why?
| | Evoked Potentials, Visual | 1 | 1984 | 42 | 0.000 |
Why?
| | Superior Colliculi | 1 | 1984 | 44 | 0.000 |
Why?
| | Half-Life | 1 | 1983 | 151 | 0.000 |
Why?
| | Aged, 80 and over | 1 | 1994 | 8265 | 0.000 |
Why?
| | Reflex, Stretch | 1 | 1981 | 10 | 0.000 |
Why?
| | Mechanoreceptors | 1 | 1981 | 17 | 0.000 |
Why?
| | Brain Mapping | 1 | 1984 | 536 | 0.000 |
Why?
| | Achilles Tendon | 1 | 1981 | 35 | 0.000 |
Why?
| | Penicillin G | 1 | 1980 | 7 | 0.000 |
Why?
| | Cerebellar Cortex | 1 | 1980 | 20 | 0.000 |
Why?
| | Nerve Block | 1 | 1981 | 103 | 0.000 |
Why?
| | Purkinje Cells | 1 | 1980 | 64 | 0.000 |
Why?
| | Leg | 1 | 1981 | 239 | 0.000 |
Why?
| | Drug Therapy, Combination | 1 | 1981 | 1047 | 0.000 |
Why?
| | Antibiotics, Antitubercular | 1 | 1956 | 35 | 0.000 |
Why?
| | Neoplasms, Experimental | 1 | 1956 | 173 | 0.000 |
Why?
| | Geniculate Bodies | 1 | 1973 | 22 | 0.000 |
Why?
| | Potassium | 1 | 1971 | 152 | 0.000 |
Why?
| | Chromatography, Gas | 1 | 1966 | 32 | 0.000 |
Why?
| | Plethysmography | 1 | 1966 | 108 | 0.000 |
Why?
| | Antineoplastic Agents | 1 | 1956 | 2194 | 0.000 |
Why?
| | Brain Diseases | 1 | 1966 | 152 | 0.000 |
Why?
| | Cardiovascular Diseases | 1 | 1966 | 2168 | 0.000 |
Why?
|
|
Miyake's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|